Brokerages Set Cara Therapeutics, Inc. (NASDAQ:CARA) Target Price at $27.84
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) has been given a consensus rating of “Hold” by the five brokerages that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation. The average 12-month price target among brokers that have issued a report on the stock in the […]
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) has been given a consensus rating of “Hold” by the five brokerages that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation. The average 12-month price target among brokers that have issued a report on the stock in the […]
